Skip to content
Menu

Tvardi Therapeutics, Inc. TVRD

Full chart Compare
Set alert

Price alert · TVRD

All alert types
1.01 USD -0.09 (-8.18%)

Regular-session close

1.00 -0.01 -0.99%

After hours · Nov 17, 4:00 PM ET

1.01 Day range 1.08
0.773 52-week range 5.69
YTD
-76.51%
1 year
-74.94%

Revenue & Expenses

Revenue Profit Costs
Income Tax Benefit$398.00KGross Profit$6.33MNet Loss$70.87MCost of Revenue$812.00KExpenses$77.59MSelling, General & Admin$26.39MResearch & Development$32.76MOther Operating Expenses$2.96MInterest Expense$8.47MOther Expenses$7.01MRevenue$7.14M

Latest period ending Dec 31, 2025 · select a line to chart its full history

TVRD annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-26.75M-28.11M-121.50M-87.53M-89.08M
-18.21M-29.40M-118.51M-85.47M-88.44M
-3.26-11.42-79.00-57.00-63.00
TVRD annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
20.73M31.61M52.18M64.15M13.45M
32.07M35.20M125.84M182.24M247.06M
11.13M40.83M68.76M23.46M19.53M
201.00K30.56M43.17M1.92M3.67M
20.95M-91.13M57.09M158.78M227.52M
TVRD annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-23.50M-18.30M-92.08M-78.73M-60.09M
-10.08M043.46M128.71M-4.75M
22.70M27.00M38.15M311.00K46.61M
-10.88M8.70M-10.47M50.29M-18.23M